Breakthrough HIV Drug Is Out Of Reach For Many Who Need It Most

Len is a gamechanging drug to prevent HIV infections, priced by Gilead at $28,200. Limited drug is available at cost to ...
The BMJ

HIV/AIDS: MSF condemns Gilead for refusing to sell it lenacapavir

Médecins Sans Frontières (MSF) has called out the makers of the HIV prevention drug lenacapavir for refusing to sell it doses of the potentially game changing treatment. In an open letter published on ...
standardmedia.co.ke

US owns up to faulty HIV test kits in African countries

For the best experience, please enable JavaScript in your browser settings. Two US state agencies have acknowledged inaccurate HIV tests in Kenya and several African ...
Business Wire

AHF: PHARMA COMPANIES SCRAPPING HIV DIAGNOSTICS ENDANGERS PATIENTS

AIDS Healthcare Foundation (AHF) supports an appeal by Médecins Sans Frontières (MSF) urging Abbott Laboratories and Becton Dickinson (BD) to continue production of point-of-care (POC) CD4 machines.

Global Fund expands commitment to improve access to HIV drug

By Christy Santhosh April 14 (Reuters) - The U.S. and the Global Fund to Fight AIDS, Tuberculosis and Malaria are stepping up ...
Medscape

Next-Day HIV Test Result Show Mixed Effects on Seeking Care

Adding laboratory-based HIV viral load (VL) test results — with a median turnaround time of 26 hours — to standard-of-care testing did not improve overall linkage to care compared with ...